Significance {#Sec1}
============

Prenatal substance use constitutes a severe public health concern. Fetal substance exposure is a preventable risk factor in the intergenerational chain of inequality and disadvantage determining the child's health at birth and short- and long-term outcome. However, prenatal interventions developed for women with substance use disorder are scarce. This randomized controlled study explored the effect of a novel 4D ultrasound parenting intervention on participation in obstetric care, fetal drug exposure and perinatal outcomes among substance using pregnant women. Retention of these high-risk patients with this new approach was very good, but a decrease in fetal exposure or improved perinatal outcomes were not observed.

Introduction {#Sec2}
============

Substance use during pregnancy constitutes a growing public health problem. In the United States, 9.4% of pregnant women self-report current alcohol use and 5.4% illicit drug use (Substance Abuse and Mental Health Services Administration [@CR29]). The worldwide prevalence rate of fetal alcohol spectrum disorder was found to be higher than estimated so far, around 23 per 1000 live births (Roozen et al. [@CR27]). In many countries, increased use of prescription opioids has been described as epidemic, also among women who are of a reproductive age or pregnant (Ollgren et al. [@CR20]; Reddy et al. [@CR25]). Recently, the number of illicit drug users, as well as the proportion of reproductive-aged women among them, has increased in Finland (Ollgren et al. [@CR20]).

Prenatal smoking, heavy drinking, and use of illicit drugs often lead to adverse neonatal outcomes, especially preterm birth and a small weight for gestational age (Forray and Foster [@CR8]; Kotelchuck et al. [@CR14]; Ludlow et al. [@CR15]). Prescription opioid use in pregnancy is known to cause perinatal complications, of which the most significant one is neonatal abstinence syndrome (Behnke et al. [@CR3]; Forray and Foster [@CR8]; Reddy et al. [@CR25]). Prenatal substance use is a preventable risk factor in the intergenerational chain of inequality and disadvantage determining the child's health at birth and developmental outcomes (Aizer and Currie [@CR1]; Behnke et al. [@CR3]; Forray and Foster [@CR8]). Nevertheless, prenatal psychosocial interventions for women suffering from substance use disorders are scarce, and studies have rarely evaluated obstetric, neonatal or child outcomes (Forray and Foster [@CR8]; Haug et al. [@CR11]; Neger and Prinz [@CR18]; Terplan et al. [@CR30]).

Substance use disorders have a strong association with inadequate prenatal care (Kotelchuck et al. [@CR14]; Roberts and Pies [@CR26]). In addition, an increased number of emergency visits and hospitalizations but less participation in preventive care has been reported among substance using pregnant women (Kotelchuck et al. [@CR14]). One specific problem is the question of how to engage these high-risk patients in prenatal healthcare (Kotelchuck et al. [@CR14]; Roberts and Pies [@CR26]).

Caregiving is a driving motivational force for recovery in substance use disorders (Jessup et al. [@CR12]). Stronger maternal--fetal attachment has been linked with favorable prenatal health practices and better neonatal outcomes among low-income women (Alhusen et al. [@CR2]). According to previous studies, maternal--fetal attachment can be strengthened by ultrasound imaging in normative pregnant women (Yarcheski et al. [@CR34]). A higher capacity for parental mentalization has been found to associate with a lower risk of relapsing into substance use (Pajulo et al. [@CR23]), as well as more sensitive caregiving (Camoirano [@CR4]) among parenting women with substance use disorders. Prenatal parental mentalization refers to the parent's ability to reflect on the fetus as a separate individual with developing capacities and emerging personality (Pajulo et al. [@CR24]). Mentalization focus has specific intervention potential in high-risk groups, and the parental mentalization capacity of substance using mothers can be enhanced with interventions (Camoirano [@CR4]).

A new prenatal intervention was designed for substance using women in public health care in Finland. The intervention aimed to enhance maternal--fetal attachment by focusing on parental mentalization using interactive 4D ultrasound imaging, and a week-by-week pregnancy diary. The objective was to assess the effect of the intervention on (1) fetal drug exposure detected by meconium testing, (2) perinatal outcomes and (3) participation in obstetric care. A randomized and controlled design was used. The intervention group was hypothesized to display better perinatal outcomes and participation in obstetric care, and less fetal drug exposure.

Methods {#Sec3}
=======

Participants {#Sec4}
------------

The study was conducted at the obstetric outpatient clinic for substance using pregnant women at Turku University Hospital between October 2011 and November 2014. The women were referred from primary health care due to (1) documented or self-reported illicit drug use, abuse of prescription medication or alcohol within 3 years prior to or during the present pregnancy, (2) and/or a sum score of ≥ 3 points on TWEAK alcohol screening (Russell [@CR28]). At admission, a psychiatric nurse offered all the eligible women an opportunity to participate. The inclusion criteria were a pregnancy duration of \< 22 gestational weeks (gwks) at referral, and a singleton pregnancy. A written informed consent was obtained from all individual participants included in the study. The participants were randomized into the intervention and control groups using a computer-generated block-randomization with a block size of four, and separate blocks for women in buprenorphine substitution treatment. Of all the eligible women (n = 126) referred, 75% consented to participate and were randomized into the intervention (n = 47) and control groups (n = 48). The participants were compensated with a 20 euros gift card at 35 gwks, with the gift being targeted to the child's needs.

The patients in both groups were scheduled visits at the obstetric outpatient clinic for pregnancy follow-up including clinical obstetric examinations, laboratory testing, and assessments of fetal growth and well-being with ultrasound imaging. Urine samples were collected for drug screening. The pregnant women were interviewed by the psychiatric nurse and the social worker on substance abuse, health and social situation based on the European Addiction Severity Index-questionnaire (EuropASI) (Kokkevi and Hartgers [@CR13]). The patient was referred to addiction treatment and psychiatric care, if needed. Based on Finnish legislation, Child Welfare authorities were already informed in the prenatal phase when substance use in pregnancy was identified. A joint meeting was scheduled for the patients in the third trimester.

Intervention {#Sec5}
------------

The intervention was based on the interactive use of 4D ultrasound imaging and the pregnancy diary. Both elements were designed to enhance prenatal parental mentalization and maternal--fetal attachment. The intervention method has been described earlier (Pajulo et al. [@CR22]). The control group received comprehensive treatment-as-usual in tertiary obstetric care. The protocol is introduced in Table [1](#Tab1){ref-type="table"}.Table 1The protocol of intervention and treatment-as-usual in the hospital obstetric outpatient clinic\< 22 gwks\< 24 gwks24 gwks30 gwks34 gwks35 gwksStandard care for the intervention and control groupsEuropASI interviews by a psychiatric nurse and a social workerUrine drug screeningSubmission of a Child Welfare NotificationObstetric assessments including fetal ultrasoundsA joint meeting with The Child Welfare authoritiesThe study protocol for the intervention and control groupsInformationRecruitmentLiteral consentRandomizationBackground dataQuestionnairesQuestionnaires20 Euros gift cardThe intervention protocol for the intervention groupPregnancy diary4D US sessionDiary session4D US sessionDiary session4D US sessionDiary session*gwks* gestational weeks, *EuropASI* The European Addiction Severity Index-questionnaire, *4D* four-dimensional ultrasound

The intervention group was offered three interactive 4D ultrasounds at 24, 30 and 34 gwks. The sessions lasted for 20--30 min, and were performed by an obstetrician and an infant mental health professional working in collaboration. During the sessions, the women were encouraged to observe the fetus and to reflect on their own emotions towards the fetus and becoming a parent for this particular child. The session started with watching the fetus according to the mother's wish. How the fetus looked, his/her facial expressions, behavior, initiatives for interaction and developing capacities were highlighted. The aim was to arouse the woman's active interest in the perspective of her child as a separate individual, and to keep the fetus in the mother's mind. Further, the intervention group received a mentalization-focused pregnancy diary and three sessions with the infant mental health professional to work with it. The diary contains an information spread sheet for each pregnancy week with psychoeducation about pregnancy, fetal development and recommended health practices. The key elements of the diary are questions and small tasks evoking the woman to consider her baby's point of view and her own experiences about becoming a parent (Pajulo et al. [@CR21]). The sessions with the infant mental health professional were arranged to give the participant the possibility to reflect on her thoughts and experiences inspired by the diary.

Data Collection and Measures {#Sec6}
----------------------------

As a part of the clinical assessment, the psychiatric nurse and the social worker interviewed the participants at admission. The interviews were based on items in the European Addiction Severity Index-questionnaire concerning somatic and mental health, substance use, employment, income, legal status and close relationships (Kokkevi and Hartgers [@CR13]). Data regarding maternal mental health was based on the interview and hospital medical records. Socio-demographic data was obtained at baseline with a questionnaire. Standardized self-report measures for the assessment of maternal mental health and prenatal parenthood were administered before the intervention (\< 24th gwks) and after the intervention (\> 34th gwks) (Pajulo et al. [@CR22]).

After birth, the meconium was analyzed qualitatively with liquid chromatography--tandem mass spectrometry (LC--MS/MS) for tramadol, morphine, 6-monoasethylmorphine, codeine, oxycodone, methadone, buprenorphine, norbuprenorphine, amphetamine, methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine and a metabolite of tetrahydrocannabinol (THC-COOH). Further, the meconium sample was screened qualitatively for more than 600 different pharmacological agents and 300 tranquilizers or illicit drugs with ultra-high performace liquid chromatography--quadrupole time-of-flight mass spectrometry (UHPLC--QTOF/MS). Meconium testing indicates intrauterine drug exposure during the second and the third trimester of pregnancy (Wabuyele et al. [@CR32]).

The data regarding participation in obstetric care and perinatal outcomes was obtained from the hospital medical records. Small for gestational age (SGA) was defined as a birth weight more than 2 standard deviations (\< 2SDs) below the population mean weight for gestational age, and preterm as a birth before 37 gwks. Finnegan scoring was used for assessment of neonatal withdrawal symptoms (Finnegan et al. [@CR7]).

Ethical Approval {#Sec7}
----------------

All procedures were in accordance with the ethical standards of the Responsible Committee on Human Experimentation and with the Helsinki Declaration of 1964 and its later amendments. The research was approved by the Joint Ethics Committee of the University of Turku and The Hospital District of Southwest Finland on 14th of June 2011. The trial was registered retrospectively in the ClinicalTrials.gov (the reference number NCT03413631).

Statistical Analyses {#Sec8}
--------------------

The sample size and power analysis were calculated based on the primary outcome of the study, prenatal depressive symptoms (EPDS), not regarding the outcomes explored in the current study.

Comparisons between the intervention and control group in nominal variables were done using chi square test or Fisher's exact test, as appropriate. The continuous variables were compared between the groups with an independent samples *t* test or a Mann--Whitney *U* test, as appropriate. The magnitudes of the effect size for the non-parametric comparisons were calculated using a formula ($\documentclass[12pt]{minimal}
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                \begin{document}$$r = Z \div \surd N$$\end{document}$) (Field [@CR6]). Statistical analyses were done with SPSS version 24, and a *p*-value of \< 0.05 was considered as significant.

Results {#Sec9}
=======

Attrition {#Sec10}
---------

Ninety-five pregnant women gave informed consent. Five participants were excluded after randomization due to pregnancy related reasons (twin pregnancy, miscarriage or induced abortion). The 90 women included in the study were recruited at a median of 13 (range 7--22) gwks. Ten women (11%) discontinued their participation during pregnancy. Eight of these women were allocated to the control group, and they withdrew consent immediately after randomization. Attrition in the control group was significantly higher than in the intervention group \[18% (8/44) vs. 4% (2/46), *p *= 0.047\] (Fig. [1](#Fig1){ref-type="fig"}). Three women in the intervention group moved to a location outside the hospital district.Fig. 1Attrition

Sample Characteristics {#Sec11}
----------------------

Descriptive data of the patients is presented in Table [2](#Tab2){ref-type="table"}. The mean age of the participants was 25 (SD 5.5) years. The pregnancy was unintended in 70% of the cases, and 71% of the women were nulliparous. The median length of substance use was 4 (range 0--28) years, 81% of the participants reported illicit drug use, and 49% both drug and alcohol abuse. Twenty-eight percent of the participants reported somatic comorbidities, most commonly respiratory, neurological, musculoskeletal or thyroid illnesses. In addition, 27% of participants were seropositive for hepatitis C. The sample characteristics were similar in both groups, indicating successful randomization.Table 2Descriptive data of the participantsAllInterventionControl*n/N* (%)*n/N* (%)*n/N* (%)df*χ*^*2*^*p*Socio demographic background Only basic education (≤ 9 years)44/80 (55)24/44 (55)20/36 (56)20.06.97 Low monthly income (\< 1000 euros)44/78 (56)25/45 (56)19/33 (58)10.03.86 Crimes in background35/85 (41)19/45 (42)16/40 (40)10.04.84 Children in foster care14/87 (16)5/45 (11)9/42 (21)11.71.19 An intimate relationship60/79 (76)28/41 (68)32/38 (84)12.74.10 Living situation at recruitment32.71.44  With the child's father47/86 (55)21/45 (47)26/41 (63)  Alone29/86 (34)18/45 (40)11/41 (27)  With someone else4/86 (5)2/45 (4)2/41 (5)  With parents6/86 (7)4/45 (9)2/41 (5) Child's father has a history of substance abuse54/82 (66)32/43 (74)22/39 (56)12.95.09Substance abuse and comorbidity Self-reported substance use (ever)  Alcohol62/90 (69)33/46 (72)29/44 (66)10.36.55  Cannabis48/90 (53)25/46 (54)23/44 (52)10.04.84  Amphetamine, other stimulants42/90 (47)21/46 (46)21/44 (48)10.04.84  Benzodiazepines34/90 (38)20/46 (43)14/44 (32)11.30.25  Buprenorphine26/90 (29)14/46 (30)12/44 (27)10.12.74 History of intravenous substance abuse40/85 (47)21/46 (46)19/39 (49)10.08.78 Smoking during pregnancy79/87 (91)43/46 (93)36/41 (88).47^a^ Reduction of smoking in pregnancy68/81 (84)38/44 (86)30/37 (81)10.41.52 Cessation of smoking in pregnancy22/74 (30)14/40 (35)8/34 (24)11.15.28 Psychiatric comorbidity69/87 (79)36/46 (78)33/41 (80)10.07.79 Somatic comorbidity24/87 (28)10/46 (22)14/41 (34)11.67.20 Psychopharmacological medication31/77 (40)15/41 (37)16/36 (44)10.49.48 Buprenorphine substitution for opioid addiction16/87 (18)9/46 (20)7/41 (17)10.09.76 Residential care during pregnancy14/77 (18)9/41 (22)5/36 (14)10.84.36 Out-patient psychiatric treatment for addiction52/78 (67)27/42 (64)25/36 (69)10.23.63 Out-patient psychiatric treatment16/77 (21)9/41 (22)7/36 (19)10.07.77*N* information available, *n* a number of affirmative responses^a^Fisher's exact test

Intervention Attendance {#Sec12}
-----------------------

The median number of attended ultrasound sessions was 3 (range 0--3) and of diary meetings 1 (range 0--3). The attendance rate at the interactive ultrasound sessions was 96% (44/46), and 74% (34/46) of the participants in the intervention group attended all three ultrasound sessions. Of those 12 women not attending all the ultrasound sessions, four delivered prematurely, two withdrew from the study and six did not attend because of logistic reasons (moving to another hospital district or problems in scheduling by the research group). The attendance rate at the diary meetings was 65% (30/46).

Participation in Obstetric Care and Perinatal Outcomes {#Sec13}
------------------------------------------------------

The number of prenatal obstetric consultations, emergency department visits, and hospital admissions was equal in both groups (Table [3](#Tab3){ref-type="table"}). However, all the scheduled clinical visits in the context of treatment-as-usual were attended by 59% of the patients in the intervention group compared to 83% in the control group \[χ^2^(1, *N *= 80) = 5.54*, p *= 0.02\]. Forty-eight percent of the women suffered from pregnancy complications, such as obesity, gestational diabetes, hypertension, pre-eclampsia or infections. Seventy-one percent of the women had an uncomplicated vaginal delivery. A vacuum extraction was performed in 11% and a cesarean section in 18% of the participants. The median birth weight was 3310 (range 645--4870) g. Thirty-five percent of the neonates were treated at the neonatal intensive care unit. One neonate in the intervention group died from asphyxia. The median pH of umbilical artery at birth was 7.25 (range 7.11--7.47). The perinatal outcomes were similar in both groups (Table [3](#Tab3){ref-type="table"}).Table 3Participation in prenatal care and perinatal outcomes in the study populationParticipation in prenatal hospital care*N*MeanSDMedianRange*pr*^d^All consultations at the obstetric outpatient clinic All758.33.78.03 to 23 Intervention408.13.58.03 to 22 Control358.44.08.03 to 230.94^a^0.01Emergency consultations at the obstetric outpatient clinic All751.11.41.00 to 7 Intervention401.01.21.00 to 5 Control351.31.61.00 to 70.39^a^0.10Prenatal hospital admissions (obstetric care) All730.41.000 to 7 Intervention380.30.800 to 4 Control350.61.200 to 70.11^a^0.19Prenatal hospital care (days) at the obstetric department All731.44.500 to 31 Intervention380.61.500 to 8 Control352.36.300 to 310.08^a^0.20Emergency department visits All710.50.900 to 4 Intervention380.61.100 to 4 Control330.30.600 to 20.27^a^0.13*Nn*%*p*Cramer's *ϕ*Participants with withdrawn visits at the obstetric clinic All802430 Intervention441841 Control366170.02^b^\*0.26Perinatal outcomes*N*MeanSDMedianRange*pr*^d^Gestational weeks at delivery All8038.92.639.525 to 42 Intervention4439.02.840.025 to 41 Control3638.82.539.028 to 420.19^a^0.15Birth weight standard deviation (SD) All76− 0.71.1− 0.8− 3.2 to 2.2 Intervention41− 0.71.0− 0.6− 3.2 to 1.6 Control35− 0.71.2− 1.0− 2.5 to 2.20.72^a^0.04Head circumference standard deviation (SD) All73− 0.50.9− 0.6− 2.8 to 2.0 Intervention38− 0.60.8− 0.8− 2.6 to 1.6 Control35− 0.41.0− 0.5− 2.8 to 2.00.28^a^0.135 min Apgar score All758.81.09.03 to 10 Intervention418.71.29.03 to 10 Control348.90.69.08 to 100.66^a^0.05Length of hospital stay, days (child) All787.912.74.50 to 90 Intervention439.314.95.00 to 90 Control356.19.34.02 to 580.21^a^0.14*Nn*%*p*Cramer's *ϕ*Small for gestational age (\< 2SD) All76912 Intervention41410 Control355140.73^c^0.07Low birth weight (\< 2500 g) All80911 Intervention44511 Control364111.00^c^0.004Preterm (\< 37 gwks) All801013 Intervention44614 Control364111.00^c^0.04Neonatal withdrawal symptoms All761216 Intervention40410 Control368220.21^c^0.17Difference between the intervention and the control group: ^a^Mann Whitney *U* test, ^b^Pearson Chi Square test, ^c^Fisher's exact test, ^d^Effect size *r* = 0.1 is referring to small effect, *r* = 0.30 is referring to medium effect, and *r* = 0.5 is referring to large effect (Field [@CR6])*N* data available, *n* a number of relevant cases\*p ≤ .05

Fetal Drug Exposure {#Sec14}
-------------------

Meconium testing was available for 89% (71/80) of the neonates, 94% (34/36) in the control and 84% (37/44) in the intervention group. Based on the meconium testing, 7% (5/71) of the newborns were exposed to illicit drugs or non-medical use of prescription drugs. A difference was not displayed in fetal drug exposure, as the meconium was screened positive for illicit drugs in 3% (1/37) of the newborns in the intervention group and 12% (4/34) in the control group (Fisher's exact test, *p *= 0.18).

Discussion {#Sec15}
==========

The objective was to explore the effect of a novel prenatal parenting intervention on participation in obstetric care, fetal drug exposure and perinatal outcomes among substance using women. Retention of these high-risk pregnant women was found to be very good in the mentalization-focused intervention using interactive 4D ultrasound and the pregnancy diary. The high attendance at the ultrasound sessions is to be especially highlighted. Interestingly, the participants in the intervention group tended to prefer the intervention sessions to the standard obstetric care visits. Contrary to the hypothesis, the intervention did not affect fetal drug exposure or the perinatal outcomes.

The participants comprised a high-risk sample with severe substance use problems and accumulation of psychosocial and health related risks (see Table [2](#Tab2){ref-type="table"}). The retention rate of 89% in the whole sample and, especially the 96% in the intervention group, can be considered very good, also when compared to previous studies. In prenatal psychosocial interventions for substance using women, such as contingency management and the motivational interview based approach, the retention rates have varied between 28 and 100% (Terplan et al. [@CR30]). Moreover, a recent systematic review reported a considerable attrition of 22--33% even in medication-assisted treatment programs for opioid dependent pregnant women (Zedler et al. [@CR35]). Parenting interventions for substance using mothers have yielded a treatment retention rate of 16--100% and a study retention rate of 33--93% (Neger and Prinz [@CR18]). Except for one study with a sample size less than ten, our study showed better patient retention than other previous studies exploring the effects of psychosocial interventions for pregnant women with illicit drug use (Terplan et al. [@CR30]).

Only 4% of the women randomized to the intervention group discontinued, compared to 18% of the control group. In the control group, the participants who dropped out discontinued immediately after randomization, when they were allocated to the group not receiving the intervention. The intervention group was offered 4D ultrasounds and specific attention and theoretically grounded support for their prenatal parenting (Pajulo et al. [@CR22]). In the current study, the high attendance at the ultrasound sessions has been emphasized. We can therefore speculate that this very good retention was due to the potential of the intervention approach, especially the parenting-focused 4D interactive ultrasounds, to engage these high-risk patients. The pregnancy diary may also have contributed to the study retention by stimulating interest towards the fetus, although the attendance at the separate diary visits was not as high. Discussions about thoughts aroused by the diary may have been challenging for these women, who are often verbally scarce (Pajulo et al. [@CR23]), and weak in insight (Goldstein et al. [@CR10]) and self-mentalization (Camoirano [@CR4]). Scheduling the diary visits with the ultrasound sessions might help to increase the attendance rate. The intervention was multifaceted and, thus the contribution of each component to the study retention could not be explored separately. Unfortunately, the difference in attrition may also reflect an attrition bias and diminish the experimental validity of the study.

Among the intervention group, we observed very good study retention but, unexpectedly, weaker compliance to standard care. The number of emergency visits, obstetric consultations and hospitalizations was similar in both groups but, contrary to our hypothesis, a higher number of patients in the intervention group missed standard antenatal visits. This finding should be considered when implementing the intervention in clinical practice. Based on the very good study retention and favorable attendance at the ultrasound session, the pregnant women found the intervention approach attractive and acceptable. We speculate that more disadvantaged patients may have engaged in the intervention because of the interest towards the intervention elements, especially the interactive 4D ultrasounds. Possible attrition bias may have been reflected in our findings concerning adherence to treatment-as-usual; in addition to which, the studied intervention may also have interfered with their compliance to standard care. The finding may be explained by the different method of encountering the substance using pregnant women in the intervention sessions compared to standard antenatal visits. Our intervention aimed to enhance their role as a caregiver and to empower them in prenatal parenting and attachment in an interactive and reflective way, strengthened by the concrete 4D visualization of the fetus combined with the parenting focus. We suggest that the patients in the intervention group may have prioritized the study visits and the intervention approach over the standard care visits. Previous research has established that vulnerable women should be supported in their parenting role already in pregnancy (Glover and Capron [@CR9]). The present intervention aims at enhancing parenting, which constitutes the most important protective environmental factor for child development after birth (Wlodarczyk et al. [@CR33]). Further research would be valuable to assess whether the 4D parenting intervention influences the early mother--baby relationship. The interest of the substance using pregnant women towards the current intervention suggests that this approach is feasible in this high-risk population, and might be beneficial to integrate into standard obstetric care.

Meconium testing is considered to be the golden standard for detecting fetal drug exposure (Wabuyele et al. [@CR32]). Unfortunately, objective means for detecting prenatal alcohol exposure are still inadequate (McQuire et al. [@CR17]). The number of positive meconium tests was relatively small considering the severity of problems related to substance use in the study population, only 7% of the newborns were exposed to drugs. Contrary to the hypothesis, the group difference was not observed in fetal drug exposure. Previous studies on prenatal psychosocial interventions for women using illicit drugs have also failed to display greater abstinence in comparison to control conditions (Terplan et al. [@CR30]). A few studies concerning brief interventions and integrated treatment approaches for pregnant women with substance use disorders have shown some promise in reducing fetal substance exposure (Farr et al. [@CR5]; Haug et al. [@CR11]; McLafferty et al. [@CR16]). However, the problem remains that substance using pregnant women rarely receive adequate prenatal care (Kotelchuck et al. [@CR14]).

The high-risk profile of the participants was reflected in the perinatal outcomes that showed a high rate of prematurity (13%), a low birth weight (11%) and perinatal mortality due to one asphyxia-related death. The Medical Birth Register shows that around 5.9% of neonates are born preterm, 4.4% have a low in birth weight and perinatal mortality is four per thousand in Finland (Vuori and Gissler [@CR31]). Our findings on the poor perinatal outcomes among substance using women are in line with previous studies (Forray and Foster [@CR8]; Kotelchuck et al. [@CR14]; Ludlow et al. [@CR15]). The perinatal outcomes were similar in both groups. Also, previous studies on prenatal psychosocial interventions have failed to display a difference in neonatal outcomes in comparison to comprehensive standard care among pregnant women with illicit drug use (Terplan et al. [@CR30]). Prenatal treatment for substance use disorders may improve neonatal outcomes, but many substance using pregnant women do not adhere to treatment (Kotelchuck et al. [@CR14]).

Not gaining statistically significant differences in perinatal outcomes and fetal drug exposure between the groups may possibly be due to the small sample size that was only able to detect moderate to large treatment effects. Further research should be undertaken to investigate the efficacy of the intervention with a larger sample. Although the study was randomized and the sample characteristics did not reveal any differences between the groups at baseline, the balance of confounding factors may have been different in the study groups due to the higher attrition in the control group. Possible retention of the more disadvantaged patients in the intervention group (attrition bias) may have compromised the detection of the intervention efficacy. The negative findings regarding the efficacy of the intervention may also simply result from the intervention not being effective enough within this very high-risk sample. The number of positive meconium drug tests was small, and conclusions concerning the effect of the intervention on fetal exposure should be drawn cautiously. Meconium drug testing may not be able to capture all the benefits of the intervention on maternal health practices. Further, all the participants were treated in the tertiary obstetric unit, and most of them were also engaged in other treatment modalities. High accessibility to medical care is associated with favorable neonatal outcomes (Aizer and Currie [@CR1]) as is attending substance abuse treatment during pregnancy (Kotelchuck et al. [@CR14]). Probably all the prenatal services have contributed to the outcomes and, thus the benefits of the studied intervention might have been difficult to differentiate in this setting. In addition, participating in the clinical trial per se may have had a favorable effect on both groups (Nijjar et al. [@CR19]).

The strengths of the study are the novel routes used for prenatal intervention, the randomized and controlled design conducted in public health care and implemented into clinical setting with a multidisciplinary approach, and the multiple sources for data collection. The sample size was relatively small, attrition was higher in the control group and only meconium testing was used as the outcome for fetal substance exposure; all of which are considered limitations.

The study demonstrated that the retention of substance using pregnant women in the novel parenting intervention using 4D ultrasound was very good. High compliance to the current study has clinical implications, because in clinical practice much effort is required to engage these high-risk patients in prenatal care (Kotelchuck et al. [@CR14]; Roberts and Pies [@CR26]). Watching the baby with a parenting focus seemed to motivate these high-risk women, although we were not able to confirm the effect of the intervention on fetal drug exposure and the perinatal outcomes. Interestingly, the pregnant women in the intervention group may have preferred the intervention sessions to standard obstetric care. We speculate that this novel intervention approach combining a parenting focus with interactive 4D ultrasound visualization of the fetus, engenders an experience of meaningful encounters for these high-risk pregnant women.
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